| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.006 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.13 | 0.007 |